In vitro and in vivo immunosuppressive characteristics of hepatocyte growth factor-modified murine mesenchymal stem cells
- PMID: 19368120
In vitro and in vivo immunosuppressive characteristics of hepatocyte growth factor-modified murine mesenchymal stem cells
Erratum in
- In Vivo. 2010 Nov-Dec;24(6):905
Abstract
Background: Previous data have proven that hepatocyte growth factor (HGF) is able to maintain the survival of mesenchymal stem cells (MSCs), rendering HGF gene modification as an optional strategy for MSC therapy. However, the question about whether gene-transferred MSCs (MSC/HGFs) exhibit more potent immunosuppressive activity remains elusive.
Materials and methods: Murine MSCs were isolated, culture-expanded and transfected by an adenovirus carrying human HGF cDNA (Ad-HGF). The transfection efficiency was evaluated by measuring HGF concentrations in the culture supernatants. An MHC-incompatible skin grafting model (C57BL-->BALB/c) was used to observe if MSC/HGF transfusion could prolong the survival time of skin transplants compared to MSCs. Furthermore, their inhibitory effects on the proliferation of T lymphocytes elicited by Con A and the activation of CD11b+ cells in mixed lymphocyte reaction were compared with carboxyfluorescein diacetate succinmidyl ester labeling and flow cytometric techniques.
Results: Ad-HGF was able to transfect mouse MSCs at high efficiency and administration of MSC/HGFs remarkably prolonged the mean survival time of skin grafts (16.73 +/- 0.57 days, p<0.01), compared with mice receiving MSCs (14.27 +/- 0.63 days), or saline (10.92 +/- 0.73 days). However, the presence of MSC/HGFs exhibited little additive impact on the suppression of T lymphocyte proliferation and activation of CD11b-positive and -negative cells in comparison with MSCs, though the inhibitory effects were evidently greater than with NIH3T3 cells and their Ad-HGF-modified counterparts.
Conclusion: MSC/HGFs inhibit in vitro immune responses in a pattern similar to MSCs, but this gene modification might have beneficial effects for transplanted cells and damaged tissue.
Similar articles
-
Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.Cell Res. 2007 Mar;17(3):240-8. doi: 10.1038/cr.2007.4. Cell Res. 2007. PMID: 17325691
-
Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia.Immunol Invest. 2008;37(7):726-39. doi: 10.1080/08820130802349940. Immunol Invest. 2008. PMID: 18821219
-
Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.Circulation. 2009 Sep 15;120(11 Suppl):S247-54. doi: 10.1161/CIRCULATIONAHA.108.843680. Circulation. 2009. PMID: 19752375
-
Immunomodulation by mesenchymal stem cells and clinical experience.J Intern Med. 2007 Nov;262(5):509-25. doi: 10.1111/j.1365-2796.2007.01844.x. J Intern Med. 2007. PMID: 17949362 Review.
-
Mesenchymal stem cells can affect solid organ allograft survival.Transplantation. 2009 May 15;87(9 Suppl):S57-62. doi: 10.1097/TP.0b013e3181a288aa. Transplantation. 2009. PMID: 19424009 Review.
Cited by
-
Improving the immunomodulatory function of mesenchymal stem cells by defined chemical approach.Front Immunol. 2022 Sep 20;13:1005426. doi: 10.3389/fimmu.2022.1005426. eCollection 2022. Front Immunol. 2022. PMID: 36203584 Free PMC article.
-
Therapeutic potentials occurring during the early differentiation process of mesenchymal stem cells in a rats model with thioacetamide-induced liver fibrosis.Korean J Hepatobiliary Pancreat Surg. 2013 Feb;17(1):21-33. doi: 10.14701/kjhbps.2013.17.1.21. Epub 2013 Feb 28. Korean J Hepatobiliary Pancreat Surg. 2013. PMID: 26155209 Free PMC article.
-
Recent advances in the therapeutic efficacy of hepatocyte growth factor gene-modified mesenchymal stem cells in multiple disease settings.J Cell Mol Med. 2022 Sep;26(18):4745-4755. doi: 10.1111/jcmm.17497. Epub 2022 Aug 3. J Cell Mol Med. 2022. PMID: 35922965 Free PMC article. Review.
-
The HPB-AML-I cell line possesses the properties of mesenchymal stem cells.J Exp Clin Cancer Res. 2010 Dec 13;29(1):163. doi: 10.1186/1756-9966-29-163. J Exp Clin Cancer Res. 2010. PMID: 21144016 Free PMC article.
-
Immunomodulatory Effect of Adipose-Derived Stem Cells: The Cutting Edge of Clinical Application.Front Cell Dev Biol. 2020 Apr 17;8:236. doi: 10.3389/fcell.2020.00236. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32363193 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials